Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation

By Kao Charlly   Daniels Mark A.   Jameson Stephen C.  

International Immunology, Vol. 17, Iss. 12, 2005-12 ,pp. : 1607-1617

Oxford University Press

Access to resources Recommend Favorite

The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3–TCR molecules after their engagement by mAb or peptide–MHC class I complexes

By Hannier S.   Triebel F.  

International Immunology, Vol. 11, Iss. 11, 1999-11 ,pp. : 1745-1752

Oxford University Press

Access to resources Recommend Favorite

BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression

By Nikolova M.   Marie-Cardine A.   Boumsell L.   Bensussan A.  

International Immunology, Vol. 14, Iss. 5, 2002-05 ,pp. : 445-451

Oxford University Press

Access to resources Recommend Favorite

Acquisition of MHC:peptide complexes by mouse CD4 + T cells may play a role in T-cell-mediated immunoregulation

By Tsang J.Y.S.   Chai J.-G.   Lechler R.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2849-2850

Elsevier

Access to resources Recommend Favorite

Chimeric 2 microglobulin/CD3 polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8 + T cells

By Margalit Alon  

International Immunology, Vol. 15, Iss. 11, 2003-11 ,pp. : 1379-1387

Oxford University Press

Access to resources Recommend Favorite